Data Availability
All data cannot be shared publicly because of P3 clinical trial. If there is data that should be disclosed, we will consider providing it.
Posted November 15, 2024.
Immunogenicity and safety of DS-5670d, an mRNA-based COVID-19 vaccine targeting omicron XBB.1.5: Results from a phase 3, randomized, active-controlled study in adults and children aged ≥12 years
